Melita Sun Jung's most recent trade in Terns Pharmaceuticals Inc was a trade of 325,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 30, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Terns Pharmaceuticals Inc | Melita Sun Jung | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 325,000 | 325,000 | - | - | Stock Option (Right to Buy) | |
Terns Pharmaceuticals Inc | Melita Sun Jung | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 5.11 per share. | 30 Jan 2025 | 2,250 | 2,250 | - | 5.1 | 11,498 | Common Stock |
Terns Pharmaceuticals Inc | Melita Sun Jung | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 475,000 | 475,000 | - | - | Stock Option (Right to buy) |